Clopidogrel-β-D-glucuronide

• Description:

  Clopidogrel-β-D-glucuronide is a metabolite of Clopidogrel (HY-15283) . Clopidogrel-β-D-glucuronide directly interacts with CYP2C8 enzyme and strongly inhibits the liver enzyme CYP2C8[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Cytochrome P450; Drug Metabolite

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cancer; Cardiovascular Disease

• Smiles:

  OC ([C@H] ([C@H] ([C@@H] ([C@H]1O) O) O) O[C@H]1OC ([C@H] (C2=C (C=CC=C2) Cl) N3CC4=C (SC=C4) CC3) =O) =O

• Molecular Formula:

  C21H22ClNO8S

• Molecular Weight:

  483.92

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]K Agergaard, et al. Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study. Clin Pharmacol Ther. 2017 Sep;102 (3) :547-553.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CYP2

• CAS Number:

  1314116-53-4